A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma. Biol Blood Marrow Transplant. 2013 May; 19(5):831-7.